Aglepristone: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Drugbox | IUPAC_name = (11β,17β)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-17-[(1Z)-1-propen-1-yl]estra-4,9-dien-3-one | image = Aglepristone.png | CAS_nu...") |
m (Protected "Aglepristone": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 30: | Line 30: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Aglepristone''' ([[International Nonproprietary Name|INN]]) (brand name '''Alizine'''; former code names '''RU-46534''', '''RU-534''') is a [[steroid]]al [[antiprogestin]] ([[progesterone receptor]] [[silent antagonist|full antagonist]]) related to [[mifepristone]] which is marketed by [[Virbac]] in several [[Europe]]an countries for use in [[veterinary medicine]].<ref name="BonaguraTwedt2013">{{cite book|author1=John D. Bonagura|author2=David C. Twedt|title=Kirk's Current Veterinary Therapy XV|url=http://books.google.com/books?id=KlJKAgAAQBAJ&pg=PT3009|date=1 December 2013|publisher=Elsevier Health Sciences|isbn=978-0-323-22762-9|pages=3009–}}</ref><ref name="Squires2010">{{cite book|author=E. James Squires|title=Applied Animal Endocrinology|url=http://books.google.com/books?id=Q-rP6Fc9-N4C&pg=PA207|year=2010|publisher=CABI|isbn=978-1-84593-755-3|pages=207–}}</ref><ref name="Papich2010">{{cite book|author=Mark G. Papich|title=Saunders Handbook of Veterinary Drugs: Small and Large Animal|url=http://books.google.com/books?id=PeJTVfaAiYAC&pg=PT120|date=3 November 2010|publisher=Elsevier Health Sciences|isbn=1-4377-0192-2|pages=120–}}</ref> It is specifically used as an [[abortifacient]] in [[pregnant]].<ref name="BonaguraTwedt2013" /><ref name="Papich2010" /><ref name="Concannon2001">{{cite book|author=Patrick W. Concannon|title=Advances in reproduction in dogs, cats and exotic carnivores: proceedings of the fourth International Symposium on Canine and Feline Reproduction, Oslo, Norway, 29 June-1 July 2000|url=http://books.google.com/books?id=q-E4AQAAIAAJ|year=2001|publisher=Journal of Reproduction and Fertility|isbn=978-0-906545-37-9}}</ref> Aglepristone, similarly to mifepristone, also possesses some [[antiglucocorticoid]] activity.{{Citation needed|date=January 2015}} | '''Aglepristone''' ([[International Nonproprietary Name|INN]]) (brand name '''Alizine'''; former code names '''RU-46534''', '''RU-534''') is a [[steroid]]al [[antiprogestin]] ([[progesterone receptor]] [[silent antagonist|full antagonist]]) related to [[mifepristone]] which is marketed by [[Virbac]] in several [[Europe]]an countries for use in [[veterinary medicine]].<ref name="BonaguraTwedt2013">{{cite book|author1=John D. Bonagura|author2=David C. Twedt|title=Kirk's Current Veterinary Therapy XV|url=http://books.google.com/books?id=KlJKAgAAQBAJ&pg=PT3009|date=1 December 2013|publisher=Elsevier Health Sciences|isbn=978-0-323-22762-9|pages=3009–}}</ref><ref name="Squires2010">{{cite book|author=E. James Squires|title=Applied Animal Endocrinology|url=http://books.google.com/books?id=Q-rP6Fc9-N4C&pg=PA207|year=2010|publisher=CABI|isbn=978-1-84593-755-3|pages=207–}}</ref><ref name="Papich2010">{{cite book|author=Mark G. Papich|title=Saunders Handbook of Veterinary Drugs: Small and Large Animal|url=http://books.google.com/books?id=PeJTVfaAiYAC&pg=PT120|date=3 November 2010|publisher=Elsevier Health Sciences|isbn=1-4377-0192-2|pages=120–}}</ref> It is specifically used as an [[abortifacient]] in [[pregnant]].<ref name="BonaguraTwedt2013" /><ref name="Papich2010" /><ref name="Concannon2001">{{cite book|author=Patrick W. Concannon|title=Advances in reproduction in dogs, cats and exotic carnivores: proceedings of the fourth International Symposium on Canine and Feline Reproduction, Oslo, Norway, 29 June-1 July 2000|url=http://books.google.com/books?id=q-E4AQAAIAAJ|year=2001|publisher=Journal of Reproduction and Fertility|isbn=978-0-906545-37-9}}</ref> Aglepristone, similarly to mifepristone, also possesses some [[antiglucocorticoid]] activity.{{Citation needed|date=January 2015}} | ||
| Line 37: | Line 42: | ||
[[Category:Abortifacients]] | [[Category:Abortifacients]] | ||
[[Category:Antiglucocorticoids]] | [[Category:Antiglucocorticoids]] | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Steroids]] | [[Category:Steroids]] | ||
Latest revision as of 17:16, 18 August 2015
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C29H37NO2 |
| Molar mass | 431.610 g/mol |
| 3D model (JSmol) | |
| |
| |
|
WikiDoc Resources for Aglepristone |
|
Articles |
|---|
|
Most recent articles on Aglepristone Most cited articles on Aglepristone |
|
Media |
|
Powerpoint slides on Aglepristone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Aglepristone at Clinical Trials.gov Clinical Trials on Aglepristone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Aglepristone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Aglepristone Discussion groups on Aglepristone Patient Handouts on Aglepristone Directions to Hospitals Treating Aglepristone Risk calculators and risk factors for Aglepristone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Aglepristone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Aglepristone (INN) (brand name Alizine; former code names RU-46534, RU-534) is a steroidal antiprogestin (progesterone receptor full antagonist) related to mifepristone which is marketed by Virbac in several European countries for use in veterinary medicine.[1][2][3] It is specifically used as an abortifacient in pregnant.[1][3][4] Aglepristone, similarly to mifepristone, also possesses some antiglucocorticoid activity.[citation needed]
References
- ↑ 1.0 1.1 John D. Bonagura; David C. Twedt (1 December 2013). Kirk's Current Veterinary Therapy XV. Elsevier Health Sciences. pp. 3009–. ISBN 978-0-323-22762-9.
- ↑ E. James Squires (2010). Applied Animal Endocrinology. CABI. pp. 207–. ISBN 978-1-84593-755-3.
- ↑ 3.0 3.1 Mark G. Papich (3 November 2010). Saunders Handbook of Veterinary Drugs: Small and Large Animal. Elsevier Health Sciences. pp. 120–. ISBN 1-4377-0192-2.
- ↑ Patrick W. Concannon (2001). Advances in reproduction in dogs, cats and exotic carnivores: proceedings of the fourth International Symposium on Canine and Feline Reproduction, Oslo, Norway, 29 June-1 July 2000. Journal of Reproduction and Fertility. ISBN 978-0-906545-37-9.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from January 2015
- Articles with invalid date parameter in template
- Abortifacients
- Antiglucocorticoids
- Drug
- Steroids